Medicare Drug Price Negotiation is here to stay
At least, it won’t be overturned by the US Supreme Court. Endpoints reports: The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare dr...
Search fresh public links, source activity, and post angles for Medicare Drug Negotiations.
Fresh curated links around Medicare drug negotiations are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
At least, it won’t be overturned by the US Supreme Court. Endpoints reports: The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare dr...
The Supreme Court refused to block Medicare's drug price negotiations, preserving more than 50% out-of-pocket savings for seniors on 10 widely used medications.
Millions of seniors are finally seeing relief from some of the highest prescription drug costs in America as Medicare’s new drug price negotiation program begins...
Prescription drug costs have long been one of the biggest financial stressors for older Americans. Now, a major shift is finally underway, and it could...
What Happened? On May 18, the Supreme Court denied all six petitions for certiorari filed by drug manufacturers challenging the IRA’s Medicare Drug Price Negotiation Program, bring...
Prescription drug costs continue to be one of the biggest financial pressures facing retirees and older Americans. In fact, many Medicare beneficiaries (around 21%) spend...
News Briefs - High Court Won't Hear Drug Manufacturer Price Negotiation Appeal - The Supreme Court declined to hear an appeal from six drug manufacturers that wanted the court to r...
By John Fritze, Tami Luhby, CNN (CNN) — The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is ex...
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible Medicare Part D...
The U.S. Supreme Court declined to hear pharmaceutical companies' challenge to the Biden administration's Medicare drug price negotiation plan. The post US Supreme Court rebuffs ph...
Medicare will cover GLP-1s for $50 starting in July — but the fine print could leave millions of seniors empty-handed.
The proposal would allow Tricare beneficiaries and VA patients to pay the lowest government-negotiated price for prescription drugs.
Major insurers including Aetna and UnitedHealth walked away from Medicare's original GLP-1 coverage plan — but a $50-a-month bridge program kicks in July 1 to keep the drugs within...
Regeneron becomes the last of 17 major drugmakers to sign on, but the secret terms and cash-only focus leave millions of insured Americans wondering what — if anything — changes fo...
FRIDAY, May 8, 2026 (Health Day News) — Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a notable shift for M...
The administration Apri 23 reached a most-favored-nation drug pricing agreement with Regeneron, the maker of the popular cholesterol medicine Praluent. This is the 17th such agreem...
President Trump has made cutting drug prices a centerpiece of his second term. He's announced deals with major drug companies and launched TrumpRx, where cash-paying patients could...
With questions already swirling about the actual affordability impact of the government’s drug purchasing portal TrumpRx, the White House is updating the platform to address a key...
WASHINGTON (AP) — White House economists estimate that President Donald Trump's deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they...
A new analysis from the Office of Inspector General found a similar net cost for drugs through vertically-integrated Part D plans compared to other plans.
President Donald Trump has repeatedly said his deals with drugmakers would bring down prescription drug prices in the U.S. But a report released by Senate Democrats finds prices ha...
The federal government has scrapped a plan to have health insurance companies fund coverage of obesity drugs for seniors, opting instead to pay for the medicine with taxpayer dolla...
The arrangement aims to create new "end-to-end employer prescription solutions" fueled by Cost Plus Drugs' software platform and drug pricing, as well as CenterWell Pharmacy's dist...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.